Pamela Wong - 22 Mar 2024 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Reporting relationship: Chief Legal Officer
Issuer ticker: MYGN
Reported as of: 22 Mar 2024
Net transaction value: -$32,048
SEC form: 4
Accepted by SEC: 25 Mar 2024, 16:32:23 UTC
Prior SEC filing: 18 Mar 2024
Source filing: View source filing
Reporting owner signature: By: Justin Hunter For: Pamela Wong

Key filing fact

Pamela Wong filed Form 4 for MYRIAD GENETICS INC (MYGN) on 25 Mar 2024.

Key facts

This page summarizes Pamela Wong's Form 4 filing for MYRIAD GENETICS INC (MYGN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 25 Mar 2024, 16:32.

Change

Previous filing in this sequence was filed on 18 Mar 2024.
Current net transaction value: -$32,048.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MYGN transaction

Common Stock

Tax liability

Transaction value: $32,048
Shares: -1,441
Change %: -2.2%
Price: $22.24
Shares after: 65,002
Date: 22 Mar 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Pamela Wong is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.

SEC remarks

Effective as of March 22, 2024, the Reporting Person is no longer serving in the role as the Company's Chief Legal Officer, and therefore, is no longer subject to Section 16 reporting.